Julie Earl

Julie Earl, Senior Researcher, Molecular epidemiology and predictive tumor markers group, Ramón y Cajal Health Research Institute (IRYCIS), completed her PhD at the University of Liverpool, UK and her postdoctoral studies at the University of Liverpool and the Spanish Cancer Research Center (CNIO) in Madrid, Spain. She specializes in cancer genetics and tumor biomarkers, particularly in digestive cancers and is a member of the Digestive Tumors Program of CIBERONC. She is the coordinator of the Spanish familial pancreatic cancer registry and also the coordinator of the BEAMing facility. The lines of research include the genetics of familial pancreatic cancer and the use of the liquid biopsy for the identification and validation of tumor biomarkers, particularly Circulating Tumor Cells (CTC) and circulating free tumor DNA detection (cftDNA). She has published more than 30 papers and currently actively participates in several national and international projects in oncology research.